India Pharmas Urge New Government To Take Pro-Pharma Stance
This article was originally published in PharmAsia News
Executive Summary
Indian pharmaceuticals urge the new government to ease up on pricing restrictions and take actions to encourage more industry spending on research and development. Several Indian pharma executives echoed the sentiment that a new government would be favorable to the industry and offered suggestions for reform, greater spending on healthcare and a greater recognition that pharmas need to be seen as part of a growth industry. One executive said the new government should drop proposals to add drugs to be covered under the country's price-control program. (Click here for more